France · Delayed Price · Currency is EUR Orchard Therapeutics Statistics
Total Valuation
Intexa has a market cap or net worth of EUR 2.53 million. The enterprise value is 2.17 million.
| Market Cap | 2.53M |
| Enterprise Value | 2.17M |
Important Dates
The last earnings date was Monday, July 28, 2025.
| Earnings Date | Jul 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Intexa has 1.01 million shares outstanding.
| Current Share Class | 1.01M |
| Shares Outstanding | 1.01M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +2.40% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 21,155 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.00 |
| PB Ratio | 0.79 |
| P/TBV Ratio | 0.79 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 22.59 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.89 |
| EV / Sales | 7.70 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 22.30, with a Debt / Equity ratio of 0.01.
| Current Ratio | 22.30 |
| Quick Ratio | 3.80 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -15.96% and return on invested capital (ROIC) is -10.56%.
| Return on Equity (ROE) | -15.96% |
| Return on Assets (ROA) | -10.09% |
| Return on Invested Capital (ROIC) | -10.56% |
| Return on Capital Employed (ROCE) | -18.02% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.08 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Intexa has paid 112,000 in taxes.
| Income Tax | 112,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.41% in the last 52 weeks. The beta is -0.26, so Intexa's price volatility has been lower than the market average.
| Beta (5Y) | -0.26 |
| 52-Week Price Change | -7.41% |
| 50-Day Moving Average | 2.60 |
| 200-Day Moving Average | 2.66 |
| Relative Strength Index (RSI) | 0.06 |
| Average Volume (20 Days) | 2 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Intexa had revenue of EUR 281,000 and -557,000 in losses. Loss per share was -0.55.
| Revenue | 281,000 |
| Gross Profit | 149,000 |
| Operating Income | -595,000 |
| Pretax Income | -445,000 |
| Net Income | -557,000 |
| EBITDA | -519,000 |
| EBIT | -595,000 |
| Loss Per Share | -0.55 |
Balance Sheet
The company has 395,000 in cash and 30,000 in debt, giving a net cash position of 365,000 or 0.36 per share.
| Cash & Cash Equivalents | 395,000 |
| Total Debt | 30,000 |
| Net Cash | 365,000 |
| Net Cash Per Share | 0.36 |
| Equity (Book Value) | 3.21M |
| Book Value Per Share | 3.17 |
| Working Capital | 3.30M |
Cash Flow
| Operating Cash Flow | 112,000 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 53.02%, with operating and profit margins of -211.74% and -198.22%.
| Gross Margin | 53.02% |
| Operating Margin | -211.74% |
| Pretax Margin | -158.36% |
| Profit Margin | -198.22% |
| EBITDA Margin | -184.70% |
| EBIT Margin | -211.74% |
| FCF Margin | n/a |
Dividends & Yields
Intexa does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -22.02% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |